1
|
Tusseau M, Eyries M, Chatron N, Coulet F, Guichet A, Colin E, Demeer B, Maillard H, Thevenon J, Lavigne C, Saillour V, Paris C, De Sainte Agathe JM, Pujalte M, Guilhem A, Dupuis-Girod S, Lesca G. Genome sequencing identify chromosome 9 inversions disrupting ENG in 2 unrelated HHT families. Eur J Med Genet 2024; 68:104919. [PMID: 38355093 DOI: 10.1016/j.ejmg.2024.104919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 01/05/2024] [Accepted: 02/04/2024] [Indexed: 02/16/2024]
Abstract
Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber disease, is a dominant inherited vascular disorder. The clinical diagnosis is based on the Curaçao criteria and pathogenic variants in the ENG and ACVRL1 genes are responsible for most cases of HHT. Four families with a negative targeted gene panel and selected by a multidisciplinary team were selected and whole-genome sequencing was performed according to the recommendations of the French National Plan for Genomic Medicine. Structural variations were confirmed by standard molecular cytogenetic analysis (FISH). In two families with a definite diagnosis of HHT, we identified two different paracentric inversions of chromosome 9, both disrupting the ENG gene. These inversions are considered as pathogenic and causative for the HHT phenotype of the patients. This is the first time structural variations are reported to cause HHT. As such balanced events are often missed by exon-based sequencing (panel, exome), structural variations may be an under-recognized cause of HHT. Genome sequencing for the detection of these events could be suggested for patients with a definite diagnosis of HHT and in whom no causative pathogenic variant was identified.
Collapse
Affiliation(s)
- M Tusseau
- Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France
| | - M Eyries
- Department of Medical Genetics, AP-HP Sorbonne University, Paris, France; Laboratoire Multisites SeqOIA, Paris, France
| | - N Chatron
- Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France
| | - F Coulet
- Department of Medical Genetics, AP-HP Sorbonne University, Paris, France; Laboratoire Multisites SeqOIA, Paris, France
| | - A Guichet
- Service de Génétique Médicale, CHU D'Angers, Angers, France
| | - E Colin
- Service de Génétique Médicale, CHU D'Angers, Angers, France
| | - B Demeer
- Genetics Department, CLAD Nord de France, CHU Amiens, France; CHIMERE, UR UPJV 7516, Université Picardie Jules Verne, Amiens, France
| | - H Maillard
- Department of Internal Medicine and Clinical Immunology, Referral Centre for Rare Systemic Autoimmune Diseases for North and North-West France (CeRAINO), CHU Lille, 59000, Lille, France
| | | | - C Lavigne
- Department of Internal Medicine and Clinical Immunology, Angers University Hospital, Angers, France
| | - V Saillour
- Laboratoire Multisites SeqOIA, Paris, France
| | - C Paris
- Laboratoire AURAGEN, Lyon, France
| | - J M De Sainte Agathe
- Department of Medical Genetics, AP-HP Sorbonne University, Paris, France; Laboratoire Multisites SeqOIA, Paris, France
| | - M Pujalte
- Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France
| | - A Guilhem
- Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France
| | - S Dupuis-Girod
- Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France
| | - G Lesca
- Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France.
| |
Collapse
|
2
|
Saade A, Wyplosz B, Baldeyrou M, Paris C, Tattevin P, Janssen C. Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France. Infect Dis Now 2024; 54:104863. [PMID: 38340891 DOI: 10.1016/j.idnow.2024.104863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Revised: 02/01/2024] [Accepted: 02/05/2024] [Indexed: 02/12/2024]
Abstract
OBJECTIVES To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level. METHODS Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions. RESULTS A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35-51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others. CONCLUSIONS Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.
Collapse
Affiliation(s)
- A Saade
- Centre régional de Pathologies professionnelles et environnementales Bretagne, Rennes, France; Service de Maladies Infectieuses et Réanimation Médicale, CHU de Rennes, Rennes, France; IRSET, Université de Rennes 1, Rennes, France.
| | - B Wyplosz
- AP-HP, Service de maladies infectieuses et tropicales, CHU Bicêtre, Le Kremlin-Bicêtre, France
| | - M Baldeyrou
- Service de Maladies Infectieuses et Réanimation Médicale, CHU de Rennes, Rennes, France
| | - C Paris
- Centre régional de Pathologies professionnelles et environnementales Bretagne, Rennes, France; IRSET, Université de Rennes 1, Rennes, France
| | - P Tattevin
- Service de Maladies Infectieuses et Réanimation Médicale, CHU de Rennes, Rennes, France
| | - C Janssen
- Centre Hospitalier Annecy Genevois, Service des maladies infectieuses et tropicales, F-74374 Annecy, France
| |
Collapse
|
3
|
Lamotte M, Paris C, Euvrard E, Pomero E, Schwartz C, Vené Y, Aubin F, Puzenat E. Long-term follow-up of patients with extensive segmental infantile hemangioma of the cervical or facial region: A French single-center prospective study. Arch Pediatr 2023:S0929-693X(23)00057-X. [PMID: 37188563 DOI: 10.1016/j.arcped.2023.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Revised: 01/29/2023] [Accepted: 03/25/2023] [Indexed: 05/17/2023]
Abstract
BACKGROUND Infantile hemangiomas (IHs) can be part of PHACE (posterior fossa anomalies, hemangioma, arterial anomalies, cardiac anomalies, eye anomalies) syndrome when they are segmental, extensive, and located on the face or neck. The initial assessment is codified and well known, but there are no recommendations for the follow-up of these patients. The aim of this study was to assess the long-term prevalence of different associated abnormalities. METHODS Patients with a history of large segmental IHs of the face or neck. diagnosed between 2011 and 2016 were included in the study. Each patient underwent an ophthalmological, dental, ENT (ear, nose, and throat), dermatological, neuro-pediatric, and radiological assessment at inclusion. Eight patients including five with PHACE syndrome were prospectively evaluated. RESULTS After a mean follow-up of 8.5 years, three patients presented with an angiomatous aspect of the oral mucosa, two with hearing loss, and two with otoscopic abnormalities. No patients developed ophthalmological abnormalities. The neurological examination was altered in three cases. Brain magnetic resonance imaging follow-up was unchanged in three out four patients and revealed atrophy of the cerebellar vermis in 1 patient. Neurodevelopmental disorders were found in five of the patients and learning difficulties were observed in five patients. The S1 location appears to be associated with a higher risk of neurodevelopmental disorders and cerebellar malformations, while the S3 location was associated with more progressive complications, including neurovascular, cardiovascular, and ENT abnormalities. CONCLUSION Our study reported late complications in patients with a large segmental IH of the face or neck, whether associated with PHACE syndrome or not, and we proposed an algorithm to optimize the long-term follow-up.
Collapse
Affiliation(s)
- M Lamotte
- Service de Dermatologie, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| | - C Paris
- Service de Pédiatrie, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| | - E Euvrard
- Service de Chirurgie maxillo-faciale, Stomatologie et Odontologie hospitalière, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| | - E Pomero
- Service de Radiologie, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| | - C Schwartz
- Service d'Ophtalmologie, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| | - Y Vené
- Service d'ORL, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| | - F Aubin
- Service de Dermatologie, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France; Inserm UMR 1098 RIGHT, Besançon, France.
| | - E Puzenat
- Service de Dermatologie, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France
| |
Collapse
|
4
|
M'be C, Scher J, Petit J, Paris C, Amani N, Burgain J. Effect of powder fractionation on anthocyanin extraction kinetics during powder reconstitution. POWDER TECHNOL 2022. [DOI: 10.1016/j.powtec.2022.118119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
5
|
Colin R, Wild P, Paris C, Boini S. Facteurs psychosociaux et accidents du travail, que dit la littérature ? ARCH MAL PROF ENVIRO 2022. [DOI: 10.1016/j.admp.2022.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
6
|
Eteve-Pitsaer C, Marty T, Nguyen A, Le Priol E, Paris C, Mebarki A, Texier N, Schück S. Psoriasis et altérations de la qualité de vie au travail: une étude avec des données issues de la base THIN® France croisées avec les contenus des réseaux sociaux analysés par l'outil Detec't®. Rev Epidemiol Sante Publique 2022. [DOI: 10.1016/j.respe.2022.09.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
7
|
Elitzur S, Vora A, Burkhardt B, Inaba H, Attarbaschi A, Baruchel A, Escherich G, Gibson B, Liu H, Loh M, Moorman A, Moricke A, Pieters R, Uyttebroeck A, Baird S, Bartram J, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks A, Grainger J, Haouy S, Heaney N, Huang M, Ingham D, Krenova Z, Kuhlen M, Lehrnbecher T, Manabe A, Niggli F, Paris C, Revel-Vilk S, Rohrlich P, Sandeep B, Sinno M, Szczepanski T, Tamesberger M, Warrier R, Wolfl M, Nirel R, Izraeli S, Borkhardt A, Schmiegelow K. EBV-DRIVEN LYMPHOID NEOPLASMS ASSOCIATED WITH ALL MAINTENANCE THERAPY: AN INTERNATIONAL OBSERVATINAL STUDY. Leuk Res 2022. [DOI: 10.1016/s0145-2126(22)00201-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
8
|
Garlantezec R, Tadié E, Heslan C, Gary-Bobo P, Oumari S, Saade A, Sitruk A, Tattevin P, Thibault V, Paris C. SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France. Infect Dis Now 2022; 52:447-452. [PMID: 36108975 PMCID: PMC9467933 DOI: 10.1016/j.idnow.2022.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Revised: 07/05/2022] [Accepted: 09/06/2022] [Indexed: 11/15/2022]
Abstract
Objectives To estimate the SARS-CoV-2 IgG seroprevalence rate in healthcare workers (HCWs) from Western France after the first 2020 wave, its determinants and the kinetics of total SARS-CoV-2 antibodies. Patients and methods Overall, 9,453 HCWs responded to a self-questionnaire and underwent a lateral flow immunoassay to assess SARS-CoV-2 IgG presence. For 72 HCWs who tested positive, total anti-nucleocapsid antibodies were assessed at day 0, 30, and 90. Results SARS-CoV-2 IgG seroprevalence rate was 1.06 % [0.86 %–1.27 %]. Factors associated with IgG presence were gender, performing upper respiratory tract samples, contact with HCWs or household members diagnosed with COVID-19. Total antibodies decreased between day 0 and day 90, with anosmia or ageusia, and were higher in HCWs older than 50 years. Conclusion We reported a low prevalence rate of IgG and identified several risk factors associated with its presence and persistence of total antibodies. Additional studies are needed to confirm these observations.
Collapse
Affiliation(s)
- R Garlantezec
- CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.
| | - E Tadié
- CHU de Rennes, F-35000 Rennes, France
| | - C Heslan
- CHU de Rennes, F-35000 Rennes, France
| | | | - S Oumari
- CHU de Rennes, F-35000 Rennes, France
| | - A Saade
- CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France
| | - A Sitruk
- CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France
| | - P Tattevin
- CHU de Rennes, Univ Rennes, INSERM U1230, IFR140, F-35033 Rennes, France
| | - V Thibault
- CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France
| | - C Paris
- CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France
| |
Collapse
|
9
|
Colin R, Wild P, Paris C, Boini S. 84 - Accidents du travail et multi-exposition aux facteurs physiques et psychosociaux. Rev Epidemiol Sante Publique 2022. [DOI: 10.1016/j.respe.2022.06.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
10
|
Paris C, Saade A, Tadié E, Nguyen Van R, Turmel V, Garlantezec R, Tattevin P. Determinants of the willingness to get the third COVID-19 vaccine dose among health care workers. Infect Dis Now 2022; 52:223-226. [PMID: 35513223 PMCID: PMC9059337 DOI: 10.1016/j.idnow.2022.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2022] [Revised: 03/04/2022] [Accepted: 04/22/2022] [Indexed: 11/23/2022]
Abstract
OBJECTIVE To characterize the willingness to get the third COVID-19 vaccine dose among health care workers (HCWs). METHODS A cross-sectional study using a self-administered questionnaire proposed on a voluntary basis to all HCWs of a French teaching hospital in October and November 2021. RESULTS Of 1,655 HCWs who completed the questionnaire, 64.2% were willing to receive the third dose, 20.1% were hesitant, and 15.7% were reluctant. On multivariate analysis, older age (P<0.0001), medical and executive staff, willingness to receive the flu vaccine (OR=5.72 [4.24-7.64]), previous vaccine scheme with ChAdOx1 nCoV-19 (AstraZeneca) (OR=2.13 [1.58-2.87]), and history of COVID-19 with a complete COVID-19 vaccine scheme (OR=2.77 [1.04-7.41]) were independent predictors of HCWs' willingness to get the third dose. CONCLUSIONS One third of HCWs were hesitant or opposed to a third COVID-19 vaccine dose. Better knowledge of determinants of the willingness to get this third dose may improve communication and vaccine strategy.
Collapse
Affiliation(s)
- C Paris
- Occupational Diseases Department, CHU de Rennes, Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, 35000 Rennes, France
| | - A Saade
- Occupational Diseases Department, CHU de Rennes, Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, 35000 Rennes, France
| | - E Tadié
- CHU de Rennes, 35000 Rennes, France
| | - R Nguyen Van
- Infectious diseases and intensive care unit, CHU de Rennes, Université de Rennes, Inserm U1230, IFR140, 35033 Rennes, France
| | - V Turmel
- CHU de Rennes, 35000 Rennes, France
| | - R Garlantezec
- Public Health Department, CHU de Rennes, Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, 35000 Rennes, France
| | - P Tattevin
- Infectious diseases and intensive care unit, CHU de Rennes, Université de Rennes, Inserm U1230, IFR140, 35033 Rennes, France.
| |
Collapse
|
11
|
Paul A, Gaiani C, Cvetkovska L, Paris C, Alexander M, Ray C, Francius G, EL-Kirat-Chatel S, Burgain J. Deciphering the impact of whey protein powder storage on protein state and powder stability. J FOOD ENG 2022. [DOI: 10.1016/j.jfoodeng.2022.111050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
Diebold L, Wirth T, Pradel V, Balandraud N, Fockens E, Paris C, Trijau S, Lafforgue P, Pham T. POS1234 IMPACT OF THE CHANGE IN ADMINISTRATION ROUTE OF TOCILIZUMAB AND ABATACEPT, DUE TO THE COVID-19 LOCKDOWN ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3126] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Among therapeutics used to treat rheumatoid arthritis (RA), Tocilizumab (TCZ) and Abatacept (ABA) are both biologic agents that can be delivered subcutaneously (SC) or intravenously (IV). During the first COVID-19 lockdown in France, all patients treated with IV TCZ or IV ABA were offered the option to switch to SC administration.Objectives:The primary aim was to assess the impact of changing the route of administration on the disease activity. The second aim was to assess whether the return to IV route at the patient’s request was associated with disease activity variation, flares, anxiety, depression and low physical activity during the lockdown.Methods:We conducted a prospective monocentric observational study. Eligibility criteria: Adult ≥ 18 years old, RA treated with IV TCZ or IV ABA with a stable dose ≥3 months, change in administration route (from IV to SC) between March 16, 2020, and April 17, 2020. The following data were collected at baseline and 6 months later (M6): demographics, RA characteristics, treatment, history of previous SC treatment, disease activity (DAS28), self-administered questionnaires on flares, RA life repercussions, physical activity, anxiety and depression (FLARE, RAID, Ricci &Gagnon, HAD).The primary outcome was the proportion of patients with a DAS28 variation>1.2 at M6. Analyses: Chi2-test for quantitative variables and Mann-Whitney test for qualitative variables. Factors associated with return to IV route identification was performed with univariate and multivariate analysis.Results:Among the 84 patients who were offered to switch their treatment route of administration, 13 refused to change their treatment. Among the 71 who switched (48 TCZ, 23 ABA), 58 had a M6 follow-up visit (13 lost of follow-up) and DAS28 was available for 49 patients at M6. Main baseline characteristics: female 81%, mean age 62.7, mean disease duration: 16.0, ACPA positive: 72.4%, mean DAS28: 2.01, previously treated with SC TCZ or ABA: 17%.At M6, the mean DAS28 variation was 0.18 ± 0.15. Ten (12.2%) patients had a DAS28 worsening>1.2 (ABA: 5/17 [29.4%] and TCZ: 5/32 [15.6%], p= 0.152) and 19 patients (32.8%) had a DAS28 worsening>0.6 (ABA: 11/17 [64.7%] and TCZ: 8/32 [25.0%], p= 0.007).At M6, 41 patients (77.4%) were back to IV route (26 TCZ, 15 ABA) at their request. The proportion of patients with a DAS28 worsening>1.2 and>0.6 in the groups return to IV versus SC maintenance were 22.5%, 42.5% versus 11.1% and 22.2% (p=0.4), respectively. The univariate analysis identified the following factors associated with the return to IV route: HAD depression score (12 vs 41, p=0.009), HAS anxiety score (12 vs 41, p=0.047) and corticosteroid use (70% vs 100%, p=0.021), in the SC maintenance vs return to IV, respectively.Conclusion:The change of administration route of TCZ and ABA during the first COVID-19 lockdown was infrequently associated with a worsening of RA disease. However, the great majority of the patients (77.4%) request to return to IV route, even without disease activity worsening. This nocebo effect was associated with higher anxiety and depression scores.Disclosure of Interests:None declared
Collapse
|
13
|
Fatih N, Paris C, Toutain S, Renoux M. Avis motivé du médecin du travail en vue de la reconnaissance en maladie professionnelle des affections psychiques : un rôle déterminant mais source de difficultés. ARCH MAL PROF ENVIRO 2021. [DOI: 10.1016/j.admp.2020.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
14
|
Dreyer SB, Upstill-Goddard R, Paulus-Hock V, Paris C, Lampraki EM, Dray E, Serrels B, Caligiuri G, Rebus S, Plenker D, Galluzzo Z, Brunton H, Cunningham R, Tesson M, Nourse C, Bailey UM, Jones M, Moran-Jones K, Wright DW, Duthie F, Oien K, Evers L, McKay CJ, McGregor GA, Gulati A, Brough R, Bajrami I, Pettitt S, Dziubinski ML, Candido J, Balkwill F, Barry ST, Grützmann R, Rahib L, Johns A, Pajic M, Froeling FEM, Beer P, Musgrove EA, Petersen GM, Ashworth A, Frame MC, Crawford HC, Simeone DM, Lord C, Mukhopadhyay D, Pilarsky C, Tuveson DA, Cooke SL, Jamieson NB, Morton JP, Sansom OJ, Bailey PJ, Biankin AV, Chang DK. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Gastroenterology 2021; 160:362-377.e13. [PMID: 33039466 PMCID: PMC8167930 DOI: 10.1053/j.gastro.2020.09.043] [Citation(s) in RCA: 62] [Impact Index Per Article: 20.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Revised: 09/27/2020] [Accepted: 09/28/2020] [Indexed: 02/06/2023]
Abstract
BACKGROUND & AIMS Continuing recalcitrance to therapy cements pancreatic cancer (PC) as the most lethal malignancy, which is set to become the second leading cause of cancer death in our society. The study aim was to investigate the association between DNA damage response (DDR), replication stress, and novel therapeutic response in PC to develop a biomarker-driven therapeutic strategy targeting DDR and replication stress in PC. METHODS We interrogated the transcriptome, genome, proteome, and functional characteristics of 61 novel PC patient-derived cell lines to define novel therapeutic strategies targeting DDR and replication stress. Validation was done in patient-derived xenografts and human PC organoids. RESULTS Patient-derived cell lines faithfully recapitulate the epithelial component of pancreatic tumors, including previously described molecular subtypes. Biomarkers of DDR deficiency, including a novel signature of homologous recombination deficiency, cosegregates with response to platinum (P < .001) and PARP inhibitor therapy (P < .001) in vitro and in vivo. We generated a novel signature of replication stress that predicts response to ATR (P < .018) and WEE1 inhibitor (P < .029) treatment in both cell lines and human PC organoids. Replication stress was enriched in the squamous subtype of PC (P < .001) but was not associated with DDR deficiency. CONCLUSIONS Replication stress and DDR deficiency are independent of each other, creating opportunities for therapy in DDR-proficient PC and after platinum therapy.
Collapse
Affiliation(s)
- Stephan B Dreyer
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom
| | - Rosie Upstill-Goddard
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | | | - Clara Paris
- Department of Pharmacological Faculty, Université Grenoble Alpes, Saint-Martin-d'Heres, France
| | - Eirini-Maria Lampraki
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Eloise Dray
- Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas
| | - Bryan Serrels
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Medical Research Council Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom
| | - Giuseppina Caligiuri
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Selma Rebus
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Dennis Plenker
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York
| | - Zachary Galluzzo
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York
| | - Holly Brunton
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Richard Cunningham
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Mathias Tesson
- Cancer Research UK Beatson Institute, Glasgow, United Kingdom
| | - Craig Nourse
- Cancer Research UK Beatson Institute, Glasgow, United Kingdom
| | - Ulla-Maja Bailey
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Marc Jones
- Stratified Medicine Scotland, Queen Elizabeth University Hospital, Glasgow, United Kingdom
| | - Kim Moran-Jones
- College of Medicine, Veterinary, and Life Sciences, University of Glasgow, Glasgow, United Kingdom
| | - Derek W Wright
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Fraser Duthie
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom
| | - Karin Oien
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom; Greater Glasgow and Clyde Bio-repository, Pathology Department, Queen Elizabeth University Hospital, Glasgow, United Kingdom
| | - Lisa Evers
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Colin J McKay
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom
| | | | - Aditi Gulati
- Cancer Research UK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
| | - Rachel Brough
- Cancer Research UK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
| | - Ilirjana Bajrami
- Cancer Research UK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
| | - Stephan Pettitt
- Cancer Research UK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
| | - Michele L Dziubinski
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan
| | - Juliana Candido
- Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
| | - Frances Balkwill
- Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
| | - Simon T Barry
- Bioscience, Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Cambridge, United Kingdom
| | - Robert Grützmann
- Department of Surgery, Universitätsklinikum Erlangen, Erlangen, Germany
| | - Lola Rahib
- Pancreatic Cancer Action Network, Manhattan Beach, California
| | - Amber Johns
- The Kinghorn Cancer Centre, Darlinghurst and Garvan Institute of Medical Research, Sydney, Australia
| | - Marina Pajic
- The Kinghorn Cancer Centre, Darlinghurst and Garvan Institute of Medical Research, Sydney, Australia
| | - Fieke E M Froeling
- Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York; Epigenetics Unit, Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, United Kingdom
| | - Phillip Beer
- Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom
| | - Elizabeth A Musgrove
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | | | - Alan Ashworth
- Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom; University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California
| | - Margaret C Frame
- Medical Research Council Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom
| | - Howard C Crawford
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan
| | - Diane M Simeone
- Pancreatic Cancer Center, Perlmutter Cancer Center, New York University Langone Health, New York, New York
| | - Chris Lord
- Cancer Research UK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
| | - Debabrata Mukhopadhyay
- Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, Florida
| | | | - David A Tuveson
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York
| | - Susanna L Cooke
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
| | - Nigel B Jamieson
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom
| | - Jennifer P Morton
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Cancer Research UK Beatson Institute, Glasgow, United Kingdom
| | - Owen J Sansom
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas
| | - Peter J Bailey
- Cancer Research UK Beatson Institute, Glasgow, United Kingdom
| | - Andrew V Biankin
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom; South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, Australia.
| | - David K Chang
- Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom; South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, Australia.
| |
Collapse
|
15
|
Dewitte JD, Paris C, Pairon J, De Blay F, Maitre B, Raherison C. Avis de la Société française de médecine du travail, de la Fédération française d’allergologie et de la Société de pneumologie de langue française, relatif à l’affectation et au retour au travail, dans le contexte de l’épidémie SARS-CoV-2 (COVID-19), des professionnels exerçant en milieu de soins et travailleurs assimilés, présentant un asthme (11 mai 2020, remplace l’avis du 7 avril 2020). ARCH MAL PROF ENVIRO 2020. [PMCID: PMC7831956 DOI: 10.1016/j.admp.2020.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
16
|
Paris C. Association Françoise et Eugène Minkowski – Centre Françoise Minkowska – Parcours de soin et santé mentale. Eur Psychiatry 2020. [DOI: 10.1016/j.eurpsy.2015.09.377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
Concernant le parcours de soins en santé mentale « L’objectif est d’améliorer sur le terrain, par des outils et des recommandations de bonne pratique, le parcours de soins et la qualité de vie des personnes présentant des troubles mentaux », précise la direction de l’amélioration de la qualité et de la sécurité des soins de la HAS. Le centre F. Minkowska géré par l’association F. et E. Minkowski a mis en perspective cet objectif pour une population migrante et refugiée afin, d’une part, d’éviter toute ghettoïsation des pratiques cliniques et, d’autre part, le souci de répondre à la demande en proposant une offre de soin tout à fait conforme au droit commun et avec un éclairage santé publique. Le projet d’établissement de ce centre medico-psychosocial s’articule sur la valorisation des bonnes pratiques en les déclinant sur trois volets. Le volet théorique autour des représentations sociales et culturelles de la santé et de la maladie mentale, le volet organisationnel avec la mise en place d’un dispositif (Mediacor) permettant d’améliorer l’accès aux soins pour les personnes migrantes et refugiées et enfin, le volet clinique avec un cadre thérapeutique reposant sur la notion de compétence culturelle. Ces trois aspects permettent de mieux appréhender les obstacles identifiés dans le parcours de soin et, par conséquent, d’y remédier.
Collapse
|
17
|
Paris C, Bennegadi R. AFPS – La psychiatrie sociale : aspects paradigmatiques. Eur Psychiatry 2020. [DOI: 10.1016/j.eurpsy.2015.09.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
Dans ce symposium, nous passerons en revue dans une première partie les références historiques et les paradigmes qui ont sous-tendu les actions complémentaires à la clinique psychiatrique. Dans un deuxième mouvement, la pluridisciplinarité comme principe consolidateur sera formalisée et enfin, il sera fait une place particulière pour l’impact du travail social dans la trame constitutive de la psychiatrie sociale. Il n’est plus contestable actuellement de chercher à évaluer l’impact des déterminants sociaux dans la genèse de la souffrance psychique ou du désordre psychologique. Les références sociales, culturelles et psychologiques s’interpénètrent pour mieux comprendre la systématisation des troubles de la personnalité ou l’apparition de décompensations névrotiques, psychotiques ou psychopathiques. Cette nouvelle approche paradigmatique situe la psychiatrie sociale au carrefour des sciences médicales, humaines et sociales et l’objectif de ce forum est d’engager cette réflexion-reconstruction.
Collapse
|
18
|
Sunyach C, Perrin J, Bretelle F, Paris C, Garlantezec R, Belacel M, Pairon JC, Sentilhes L, Delva F, Brochard P. A French network for prevention and reduction of reproductive risk in couples and pregnant women. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz186.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Since 2013, several international (ASRM, FIGO, ACOG) and French (ANSES) learned societies and the French National Health and Environment Plan (2015-2019) urged to take into account exposures to environmental reprotoxic substances during standard care of infertile couples and pregnant women. However perinatal health professionals hardly incorporate this recommendation into practice.
Objectives
To create a network of platforms to addressing the environmental aspects that can impact the pregnancy chances of infertile couples after ART and pregnancy outcomes.
We asked regional health authorities in France to provide funding for multidisciplinary hospital structures, in conjunction with clinical-biological reproductive health and gynecology-obstetric centers. Expertise, as well as information leaflets and risk detection tools have been shared.
Results
Platforms of counselling and prevention have been set up in the University Hospitals of Bordeaux, Marseille, Rennes, Créteil and Paris Fernand-Widal. Infertile couples and pregnant women, referred by reproductive physicians, benefit from personalized management of their domestic/professional reprotoxic exposures by addictology/tobacco, dietetics, occupational health and environmental pathology professionals. The network organizes an annual scientific day and a common database of exposure is being set up.
Conclusions
The PREVENIR (PREVENTION - ENVIRONMENT - Reproduction) network of platforms allows perinatal health professionals to refer their patients in order to optimize their chance of pregnancy through personalized and multidisciplinary care. The lifestyle changes initiated through this approach will also improve pregnancy outcomes and child health.
Key messages
A French network for the prevention and reduction of reproductive risk in infertile couples and pregnant women: the PREVENIR platforms (PREVENTION - ENVIRONMENT - Reproduction) is being established. Perinatal health professionals of multidisciplinary platforms engage into preventive actions to limit the exposure to environmental hazards during preconception and pregnancy.
Collapse
Affiliation(s)
| | - J Perrin
- Conception Hospital, Marseille, France
- Mediterranean Institute of Marine and Terrestrial Biodiversity and Ecology, Marseille, France
| | - F Bretelle
- Timone Hospital, Marseille, France
- Mediterranean Network (PACA CORSE MONACO Perinatal Network), Marseille, France
- Mediterranee Infection, Marseille, France
| | - C Paris
- University Hospital, Rennes, France
| | | | - M Belacel
- Intercomunal Center Hospital, Creteil, France
| | - J-C Pairon
- Intercomunal Center Hospital, Creteil, France
| | | | - F Delva
- University Hospital, Bordeaux, France
| | | |
Collapse
|
19
|
Lannes F, Le Thi K, Cherif C, Benizri S, Fazli L, Paris C, Gleave M, Barthelemy P, Rocchi P. DDX5, une nouvelle cible thérapeutique dans le cancer de prostate résistant à la castration. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
20
|
Riblier-Dehen D, Luc A, Paris C, Clin B, Gislard A, Pairon JC, Thaon I. [Psychological impacts of follow up for occupational asbestos exposure. Consequences after compensation for occupational disease in the SPP-A cohort]. Rev Mal Respir 2019; 36:924-936. [PMID: 31522950 DOI: 10.1016/j.rmr.2019.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Accepted: 06/27/2019] [Indexed: 11/18/2022]
Abstract
INTRODUCTION In France, long-term follow-up after occupational exposure to asbestos is recommended. This study looked at the psychological consequences in the longer term following a CT-scan, in particular the impact of having received compensation for an occupational disease. METHODS As part of an asbestos post-exposure survey study (APExS), volunteers from Normandy were asked to complete self-assessment questionnaires about their psychological condition at different points during follow-up, including a psychological questionnaire before, then 6 months, and finally 18 to 24 months after their chest CT-scan. Information collected from 622 individuals were analyzed based on information provided as to the result of the screening and whether they had received compensation for having an occupational disease. RESULTS The identification of an occupational disease eligible for compensation is associated with a long term increase in psychological distress. The impact of psychological state during follow-up is greater in men who reported receiving occupational disease compensation. The discovery of an asbestos-related disease during the screening is associated with a negative perception of general health and an increase in psychological distress. CONCLUSION The receipt of compensation of an occupational disease does not seem to compensate for the negative psychological impact related to the discovery of a disease during the asbestos post-exposure follow-up.
Collapse
Affiliation(s)
- D Riblier-Dehen
- Centre de consultations de pathologies professionnelles, CHRU de Nancy, bâtiment P.-Canton, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.
| | - A Luc
- DRCI, département MPI, unité de méthodologie, data management et statistique, CHRU de Nancy, 54000 Nancy, France
| | - C Paris
- Service de santé au travail et de pathologie professionnelle et environnementale, CHRU de Rennes, 35033 Rennes, France; Inserm, U1085 IRSET, équipe ESTER, 35000 Rennes, France
| | - B Clin
- Inserm U1086, « ANTICIPE », 14076 Caen, France; Service de santé au travail et pathologie professionnelle, CHU de Caen, 14033 Caen, France; Université de Caen Normandie, 14032 Caen, France
| | - A Gislard
- Normandie université, UNIROUEN, UNICAEN, ABTE, 76000 Rouen, France; Centre de consultations de pathologie professionnelle, CHU de Rouen, 76031 Rouen cedex, France
| | - J-C Pairon
- Inserm, U955, équipe 4, 94010 Créteil, France; Faculté de médecine, institut Santé-Travail Paris-Est, université Paris-Est Créteil, 94010 Créteil, France; Service de pathologies professionnelles et de l'environnement, centre hospitalier intercommunal Créteil, 94010 Créteil, France
| | - I Thaon
- Centre de consultations de pathologies professionnelles, CHRU de Nancy, bâtiment P.-Canton, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France; Équipe MICS, université de Lorraine, APEMAC, 54000 Nancy, France
| |
Collapse
|
21
|
Sanges S, Jeanpierre E, Lopez B, Russick J, Delignat S, Dubois R, Hachulla E, Paris C, Susen S, Launay D, Lacroix-Desmazes S, Terriou L. Association hémophilie acquise et maladie associée aux IgG4 : présentation d’un cas et étude physiopathologique. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
22
|
Durand-Moreau Q, Descatha A, Paris C, Roquelaure Y, Takala J. Que retenir du 32e Congrès de la Commission internationale de la santé au travail (CIST-ICOH) ? ARCH MAL PROF ENVIRO 2018. [DOI: 10.1016/j.admp.2018.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
23
|
Choupin T, Fayolle B, Régnier G, Paris C, Cinquin J, Brulé B. Macromolecular modifications of poly(etherketoneketone) (PEKK) copolymer at the melting state. Polym Degrad Stab 2018. [DOI: 10.1016/j.polymdegradstab.2018.07.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
24
|
Plantier L, Beydon N, Chambellan A, Degano B, Delclaux C, Dewitte JD, Dinh-Xuan AT, Garcia G, Kauffmann C, Paris C, Perez T, Poussel M, Wuyam B, Zerah-Lancner F, Chenuel B. [Guidelines for methacholine provocation testing]. Rev Mal Respir 2018; 35:759-775. [PMID: 30097294 DOI: 10.1016/j.rmr.2018.02.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2017] [Accepted: 02/15/2018] [Indexed: 12/01/2022]
Abstract
Bronchial challenge with the direct bronchoconstrictor agent methacholine is commonly used for the diagnosis of asthma. The "Lung Function" thematic group of the French Pulmonology Society (SPLF) elaborated a series of guidelines for the performance and the interpretation of methacholine challenge testing, based on French clinical guideline methodology. Specifically, guidelines are provided with regard to the choice of judgment criteria, the management of deep inspirations, and the role of methacholine bronchial challenge in the care of asthma, exercise-induced asthma, and professional asthma.
Collapse
Affiliation(s)
- L Plantier
- CEPR/Inserm UMR1100, CHRU de Tours, service de pneumologie et explorations fonctionnelles respiratoires, université François-Rabelais, 37044 Tours cedex 9, France.
| | - N Beydon
- Unité fonctionnelle d'exploration fonctionnelle respiratoire et du sommeil, AP-HP, hôpital Armand-Trousseau, 75012 Paris, France
| | - A Chambellan
- Inserm UMR1087, explorations fonctionnelles et réhabilitation respiratoire, l'institut du thorax, CHU, 44093 Nantes cedex 1, France
| | - B Degano
- Service d'explorations fonctionnelles, hôpital Jean-Minjoz, 25000 Besançon, France
| | - C Delclaux
- Inserm U1141, DHU PROTECT, service de physiologie explorations fonctionnelles pédiatriques-CPPS, AP-HP, hôpital Robert-Debré, université Paris Diderot, 75019 Paris, France
| | - J-D Dewitte
- Santé au travail-laboratoire d'étude et de recherche en sociologie, UFR médecine et sciences de la santé, université de Bretagne occidentale, 29238 Brest cedex 3, France
| | - A T Dinh-Xuan
- Service de physiologie-explorations fonctionnelles, université Paris Descartes, AP-HP, hôpital Cochin, 75014 Paris, France
| | - G Garcia
- Service de physiologie, Inserm UMR999, AP-HP, hôpital de Bicêtre, 94270 Le Kremlin-Bicêtre cedex, France
| | - C Kauffmann
- Service d'explorations fonctionnelles respiratoires, CHU, 63000 Clermont-Ferrand, France
| | - C Paris
- EA7892, service de pathologie professionnelle, université de Lorraine, CHU de Nancy, 54500 Vandœuvre-Les-Nancy, France
| | - T Perez
- Clinique de pneumologie, centre de compétences maladies pulmonaires rares, CHRU de Lille, hôpital Albert-Calmette, 59037 Lille, France
| | - M Poussel
- Antenne médicale de prévention du dopage, EA 3450, service des examens de la fonction respiratoire et de l'aptitude à l'exercice médecine du sport, CHRU de Nancy Brabois, 54500 Vandœuvre-lès-Nancy, France
| | - B Wuyam
- Laboratoire HP2, Inserm 1042, service sport et pathologies, CHU de Grenoble, hôpital Sud, 38130 Echirolles, France
| | - F Zerah-Lancner
- Service de physiologie-explorations fonctionnelles, AP-HP, hôpital Henri-Mondor, 94000 Créteil, France
| | - B Chenuel
- Antenne médicale de prévention du dopage, EA 3450, service des examens de la fonction respiratoire et de l'aptitude à l'exercice médecine du sport, CHRU de Nancy Brabois, 54500 Vandœuvre-lès-Nancy, France
| | | |
Collapse
|
25
|
Garrigue D, Godier A, Glacet A, Labreuche J, Kipnis E, Paris C, Duhamel A, Resch E, Bauters A, Machuron F, Renom P, Goldstein P, Tavernier B, Sailliol A, Susen S. French lyophilized plasma versus fresh frozen plasma for the initial management of trauma-induced coagulopathy: a randomized open-label trial. J Thromb Haemost 2018; 16:481-489. [PMID: 29274254 DOI: 10.1111/jth.13929] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2017] [Indexed: 01/08/2023]
Abstract
Essentials An immediate supply of plasma in case of trauma-induced coagulopathy is required. The Traucc trial compared French Lyophilised Plasma (FLyP) and Fresh Frozen Plasma (FFP). FLyP achieved higher fibrinogen concentrations compared with FFP. FLyP led to a more rapid coagulopathy improvement than FFP. SUMMARY Background Guidelines recommend beginning hemostatic resuscitation immediately in trauma patients. We aimed to investigate if French lyophilized plasma (FLyP) was more effective than fresh frozen plasma (FFP) for the initial management of trauma-induced coagulopathy. Methods In an open-label, phase 3, randomized trial (NCT02750150), we enrolled adult trauma patients requiring an emergency pack of 4 plasma units within 6 h of injury. We randomly assigned patients to receive 4-FLyP units or 4-FFP units. The primary endpoint was fibrinogen concentration at 45 min after randomization. Secondary outcomes included time to transfusion, changes in hemostatic parameters at different time-points, blood product requirements and 30-day in-hospital mortality. Results Forty-eight patients were randomized (FLyP, n = 24; FFP, n = 24). FLyP reduced the time from randomization to transfusion of first plasma unit compared with FFP (median[IQR],14[5-30] vs. 77[64-90] min). FLyP achieved a higher fibrinogen concentration 45 min after randomization compared with FFP (baseline-adjusted mean difference, 0.29 g L-1 ; 95% confidence interval [CI], 0.08-0.49) and a greater improvement in prothrombin time ratio, factor V and factor II. The between-group differences in coagulation parameters remained significant at 6 h. FLyP reduced fibrinogen concentrate requirements. Thirty-day in-hospital mortality rate was 22% with FLyP and 29% with FFP. Conclusion FLyP led to a more rapid, pronounced and extended increase in fibrinogen concentrations and coagulopathy improvement compared with FFP in the initial management of trauma patients. FLyP represents an attractive option for trauma management, especially when facing logistical issues such as combat casualties or mass casualties related to terror attacks or disasters.
Collapse
Affiliation(s)
- D Garrigue
- CHU de Lille, Pôle d'Anesthésie-Réanimation, Lille, France
- CHU Lille, Pôle de l'Urgence, Lille, France
| | - A Godier
- Service d'Anesthésie-Réanimation, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
- NSERM, UMR-S1140, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - A Glacet
- CHU de Lille, Pôle d'Anesthésie-Réanimation, Lille, France
- CHU Lille, Pôle de l'Urgence, Lille, France
| | - J Labreuche
- Université Lille, CHU Lille, EA 2694 - Santé Publique: Épidémiologie et Qualité des Soins, Lille, France
| | - E Kipnis
- CHU de Lille, Pôle d'Anesthésie-Réanimation, Lille, France
- Université Lille, EA 7366, Lille, France
| | - C Paris
- CHU de Lille, Institut d'Hématologie-Transfusion, Lille, France
| | - A Duhamel
- Université Lille, CHU Lille, EA 2694 - Santé Publique: Épidémiologie et Qualité des Soins, Lille, France
| | - E Resch
- EFS Hauts de France, Lille, France
| | - A Bauters
- CHU de Lille, Institut d'Hématologie-Transfusion, Lille, France
| | - F Machuron
- Université Lille, CHU Lille, EA 2694 - Santé Publique: Épidémiologie et Qualité des Soins, Lille, France
| | - P Renom
- CHU de Lille, Institut d'Hématologie-Transfusion, Lille, France
| | - P Goldstein
- CHU de Lille, Pôle d'Anesthésie-Réanimation, Lille, France
- CHU Lille, Pôle de l'Urgence, Lille, France
| | - B Tavernier
- CHU de Lille, Pôle d'Anesthésie-Réanimation, Lille, France
| | - A Sailliol
- Centre de Transfusion Sanguine des Armées, Clamart, France
| | - S Susen
- CHU de Lille, Institut d'Hématologie-Transfusion, Lille, France
- Université Lille, Inserm, CHU Lille, U1011 - EGID, Lille, France
| |
Collapse
|
26
|
Wild P, Mével H, Penven E, Zmirou-Navier D, Barbaud A, Bohadana A, Paris C. FeNO levels increase with degree of sensitisation in apprentices at risk of occupational asthma. Int J Tuberc Lung Dis 2017; 21:1194-1200. [DOI: 10.5588/ijtld.16.0758] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- P. Wild
- Institut National de Recherche et de Sécurité, Vandoeuvre-lès-Nancy
| | - H. Mével
- Institut National de Recherche et de Sécurité, Vandoeuvre-lès-Nancy
| | - E. Penven
- Occupational Diseases Department, Nancy University Hospital, Nancy
| | - D. Zmirou-Navier
- Department of Environmental and Occupational Health, Ecole des Hautes Etudes en Santé Publique, Rennes, Lorraine University Medical School, Nancy
| | - A. Barbaud
- Lorraine University Medical School, Nancy, Dermatology and Allergy Department, Tenon Hospital, Paris, France
| | - A. Bohadana
- Respiratory Research Unit, Pulmonary Institute, Shaare Zeded Medical Center, Jerusalem, Israel
| | - C. Paris
- Occupational Diseases Department, Nancy University Hospital, Nancy, Lorraine University Medical School, Nancy
| |
Collapse
|
27
|
Karaki N, Aljawish A, Muniglia L, Bouguet-Bonnet S, Leclerc S, Paris C, Jasniewski J, Humeau-Virot C. Functionalization of pectin with laccase-mediated oxidation products of ferulic acid. Enzyme Microb Technol 2017. [DOI: 10.1016/j.enzmictec.2017.05.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
28
|
Vincent F, Rauch A, Loobuyck V, Spillemaeker H, Nix C, Vincentelli A, Moussa M, Lemesle G, Paris C, Dupont A, Richardson M, Staels B, Lenting P, Van Belle E, Susen S. P5812Acquired von willebrand factor defect under continuous-flow ventricular assist devices: modulation by dynamic changes of pulsatility. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Poussel M, Penven E, Essari LA, Chabot F, Barbaud A, Paris C. Occupational Asthma to Detergent Protease Associated With a Late-Phase Neutrophilic Cutaneous Response. J Investig Allergol Clin Immunol 2017; 27:60-62. [PMID: 28211347 DOI: 10.18176/jiaci.0115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M Poussel
- Department of Pulmonary Function Testing and Exercise Physiology, CHRU Nancy, Nancy, France.,EA 3450 DevAH - Development, Adaptation and Disadvantage, Cardiorespiratory Regulations and Motor Control, Université de Lorraine, Vandoeuvre-lès-Nancy, France
| | - E Penven
- Occupational Diseases Department, Bâtiment Philippe Canton, CHRU Nancy, Vandoeuvre-lès-Nancy, France.,EA-7298 INGRES, Université de Lorraine, Vandoeuvre-lès-Nancy, France
| | - L A Essari
- Department of Pulmonary Function Testing and Exercise Physiology, CHRU Nancy, Nancy, France.,Pulmonology Department, CHRU Nancy, Nancy, France
| | - F Chabot
- EA-7298 INGRES, Université de Lorraine, Vandoeuvre-lès-Nancy, France.,Pulmonology Department, CHRU Nancy, Nancy, France
| | - A Barbaud
- EA-7298 INGRES, Université de Lorraine, Vandoeuvre-lès-Nancy, France.,Department of Dermatology and Allergy, CHRU Nancy, Vandoeuvre-lès-Nancy, France
| | - C Paris
- Occupational Diseases Department, Bâtiment Philippe Canton, CHRU Nancy, Vandoeuvre-lès-Nancy, France.,EA-7298 INGRES, Université de Lorraine, Vandoeuvre-lès-Nancy, France
| |
Collapse
|
30
|
Choupin T, Fayolle B, Régnier G, Paris C, Cinquin J, Brulé B. Isothermal crystallization kinetic modeling of poly(etherketoneketone) (PEKK) copolymer. POLYMER 2017. [DOI: 10.1016/j.polymer.2017.01.033] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
31
|
Bensefa-Colas L, Brunel S, Bonneterre V, Paris C, Larabi L, Le-Barbier M. Apport de l’exploitation des données RNV3P pour la connaissance des pathologies professionnelles : situations professionnelles à risque, tendances temporelles, recherche de signaux pertinents pour l’émergence, approche territoriale, croisement avec des données externes. ARCH MAL PROF ENVIRO 2016. [DOI: 10.1016/j.admp.2016.10.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
32
|
Paris C. Plaques pleurales et co-expositions à l’amiante, à la silice, aux fibres minérales artificielles et aux fibres céramiques réfractaires. ARCH MAL PROF ENVIRO 2016. [DOI: 10.1016/j.admp.2016.10.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
33
|
Valence S, Garel C, Barth M, Toutain A, Paris C, Amsallem D, Barthez MA, Mayer M, Rodriguez D, Burglen L. RELN and VLDLR mutations underlie two distinguishable clinico-radiological phenotypes. Clin Genet 2016; 90:545-549. [PMID: 27000652 DOI: 10.1111/cge.12779] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Revised: 03/08/2016] [Accepted: 03/09/2016] [Indexed: 12/17/2022]
Abstract
Pontocerebellar hypoplasias (PCH) are characterized by lack of development and/or early neurodegeneration of cerebellum and brainstem. We report five patients referred for PCH, showing atypical clinical and magnetic resonance imaging (MRI) features suggestive of defects in the Reelin pathway. We screened for mutations in RELN or VLDLR and compared the phenotype of these patients with that of previously reported patients. All patients had profound cerebellar hypoplasia on MRI with peculiar cerebellar morphology, associated with flattened pons and neocortical abnormalities. Patient 1 had profound motor and intellectual disability with moderate lissencephaly suggestive of RELN mutations and was shown to harbor a splicing homozygous RELN mutation. The four other patients had a milder phenotype consistent with CARMQ1 (cerebellar ataxia and mental retardation with or without quadrupedal locomotion). These patients showed mild simplification or thickening of cortical gyration and had VLDLR mutations. Reelin signaling regulates neuronal migration in the developing mammalian brain. VLDLR is a key component of the Reelin pathway. Our patients had a very small and dysplatic cerebellar vermis that should suggest the involvement of these genes. Moreover, differences in clinical severity, involvement of the cerebellar hemispheres, together with the severity of the neocortical defect, enables RELN-mutated patients to be distinguished from VLDLR-mutated patients.
Collapse
Affiliation(s)
- S Valence
- APHP, GHUEP, Hôpital Armand Trousseau, Centre de Référence 'Malformations et maladies congénitales du cervelet', Paris, France.,APHP, GHUEP, Hôpital Armand-Trousseau, Service de Neuropédiatrie, Paris, France.,Sorbonne Universités, UPMC Université Paris 06, GRC-UPMC ConCer-LD, Paris, France
| | - C Garel
- APHP, GHUEP, Hôpital Armand Trousseau, Centre de Référence 'Malformations et maladies congénitales du cervelet', Paris, France.,APHP, GHUEP, Hôpital Armand-Trousseau, Service de Radiologie, Paris, France
| | - M Barth
- Service de Génétique, CHU d'Angers, Angers, France
| | - A Toutain
- Service de Génétique, CHU de Tours, and UMR_INSERM U930, Faculté de Médecine, Université François Rabelais, Tours, France
| | - C Paris
- Service de Neurologie Pédiatrique, CHU J Minjoz, Besançon, France
| | - D Amsallem
- Service de Neurologie Pédiatrique, CHU J Minjoz, Besançon, France
| | - M-A Barthez
- Service de Neurologie Pédiatrique, CHU de Tours, Tours, France
| | - M Mayer
- APHP, GHUEP, Hôpital Armand-Trousseau, Service de Neuropédiatrie, Paris, France
| | - D Rodriguez
- APHP, GHUEP, Hôpital Armand Trousseau, Centre de Référence 'Malformations et maladies congénitales du cervelet', Paris, France.,APHP, GHUEP, Hôpital Armand-Trousseau, Service de Neuropédiatrie, Paris, France.,Sorbonne Universités, UPMC Université Paris 06, GRC-UPMC ConCer-LD, Paris, France
| | - L Burglen
- APHP, GHUEP, Hôpital Armand Trousseau, Centre de Référence 'Malformations et maladies congénitales du cervelet', Paris, France.,Neuroprotection du cerveau en développement, INSERM U1141, Paris, France.,APHP, GHUEP, Hôpital Armand-Trousseau, Département de Génétique, Paris, France
| |
Collapse
|
34
|
Paris C, Herin F, Penven E, Thaon I, Richard C, Jacquenet S, Barbaud A, Poussel M. First evidence of occupational asthma to argan powder in a cosmetic factory. Allergy 2016; 71:550-5. [PMID: 26606505 DOI: 10.1111/all.12811] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/16/2015] [Indexed: 11/28/2022]
Abstract
BACKGROUND Argan is used worldwide in numerous cosmetic products, as this fruit is supposed to have many beneficial properties on health. New cases of allergy can be expected with the growing use of argan. We investigated all workers (9) employed by a cosmetic factory and exposed to argan powder to identify possible allergies related to exposure to argan powder. METHODS Patients were investigated in the occupational disease department and, according to their symptoms, underwent pulmonary function testing, methacholine challenge, specific inhalation challenge to argan powder, skin prick tests, and immunoblotting analysis. RESULTS We report three cases of occupational asthma to argan powder and a probable case of rhinitis. Fifteen argan proteins were recognized by the patients' IgE. Identification of proteins, cross-reactions to nuts, and ELISA inhibition tests suggested that some argan allergens can cross-react in vitro with hazelnut allergens, including 11S globulin and vicilin. CONCLUSION High-level exposure to argan powder should be considered to be a potential cause of IgE-mediated allergy, and workers handling argan powder should be carefully investigated.
Collapse
Affiliation(s)
- C. Paris
- Occupational Diseases Department; Bâtiment Philippe Canton; CHU Nancy; Vandoeuvre-lès-Nancy France
- EA-7298 INGRES; Université de Lorraine; Nancy France
| | - F. Herin
- INSERM UMR1027 (The French National Institute of Health and Medical Research); Toulouse France
- University of Toulouse III Paul Sabatier; Toulouse France
- Occupational diseases department; Toulouse University Hospital; Toulouse France
| | - E. Penven
- Occupational Diseases Department; Bâtiment Philippe Canton; CHU Nancy; Vandoeuvre-lès-Nancy France
- EA-7298 INGRES; Université de Lorraine; Nancy France
| | - I. Thaon
- Occupational Diseases Department; Bâtiment Philippe Canton; CHU Nancy; Vandoeuvre-lès-Nancy France
- EA-7298 INGRES; Université de Lorraine; Nancy France
| | | | | | - A. Barbaud
- EA-7298 INGRES; Université de Lorraine; Nancy France
- Dermatology and Allergy Department; Bâtiment Philippe Canton; CHU Nancy; Vandoeuvre-lès-Nancy France
| | - M. Poussel
- Department of Pulmonary Function Testing and Exercise Physiology; CHU Nancy; Vandoeuvre-lès-Nancy France
- EA 3450 DevAH - Development, Adaptation and Disadvantage. Cardiorespiratory regulations and motor control; Université de Lorraine; Nancy France
| |
Collapse
|
35
|
Vella-Boucaud J, Pairon J, Duburcq A, Brochard P, Chamming's S, Luc A, Lebargy F, Detournay B, Clin-Godard B, Gislard A, Paris C, Chouaid C, Andujar P. Analyse coût–efficacité du dépistage du cancer du poumon chez les sujets exposés à des cancérigènes respiratoires. Rev Mal Respir 2016. [DOI: 10.1016/j.rmr.2015.10.679] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
36
|
Aparici-Espert I, Cuquerella MC, Paris C, Lhiaubet-Vallet V, Miranda MA. Photocages for protection and controlled release of bioactive compounds. Chem Commun (Camb) 2016; 52:14215-14218. [DOI: 10.1039/c6cc08175d] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
A photoactivatable ketoprofen–avobenzone dyad was designed for the protection and controlled release of phototoxic drugs.
Collapse
Affiliation(s)
- I. Aparici-Espert
- Instituto Universitario Mixto de Tecnología Química (UPV-CSIC)
- Universitat Politècnica de València
- Consejo Superior de Investigaciones Científicas
- 46022 Valencia
- Spain
| | - M. C. Cuquerella
- Instituto Universitario Mixto de Tecnología Química (UPV-CSIC)
- Universitat Politècnica de València
- Consejo Superior de Investigaciones Científicas
- 46022 Valencia
- Spain
| | - C. Paris
- Instituto Universitario Mixto de Tecnología Química (UPV-CSIC)
- Universitat Politècnica de València
- Consejo Superior de Investigaciones Científicas
- 46022 Valencia
- Spain
| | - V. Lhiaubet-Vallet
- Instituto Universitario Mixto de Tecnología Química (UPV-CSIC)
- Universitat Politècnica de València
- Consejo Superior de Investigaciones Científicas
- 46022 Valencia
- Spain
| | - M. A. Miranda
- Instituto Universitario Mixto de Tecnología Química (UPV-CSIC)
- Universitat Politècnica de València
- Consejo Superior de Investigaciones Científicas
- 46022 Valencia
- Spain
| |
Collapse
|
37
|
Paris C, Derex L. [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives]. Rev Neurol (Paris) 2015; 171:866-75. [PMID: 26563662 DOI: 10.1016/j.neurol.2015.09.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2015] [Revised: 08/11/2015] [Accepted: 09/01/2015] [Indexed: 11/18/2022]
Abstract
New therapeutic strategies are under evaluation to improve the treatment of acute ischemic stroke (AIS). Approaches combining intravenous (IV) thrombolysis with recombinant tissue plasminogen activator (rt-PA) and antithrombotic agents are currently evaluated. The combination of IV rt-PA and aspirin showed a high rate of intracranial hemorrhage whereas the association of rt-PA and eptifibatide seems more promising. The results of recent studies evaluating the administration of eptifibatide or argatroban in conjunction with conventional IV thrombolysis with rt-PA are expected to clarify the safety and efficacy of these treatments. More fibrin-specific plasminogen activators, tenecteplase and desmoteplase, are also investigated. These fibrinolytic agents showed a favorable safety profile but their efficacy in AIS remains uncertain. While phase III studies, DIAS-3 and DIAS-4, evaluating IV desmoteplase up to nine hours after stroke onset did not meet the primary endpoint, the results of studies comparing IV tenecteplase and IV rt-PA are expected.
Collapse
Affiliation(s)
- C Paris
- Faculté de pharmacie de Lyon, 8, avenue Rockefeller, 69373 Lyon cedex 08, France
| | - L Derex
- Unité neurovasculaire, service de neurologie, hôpital neurologique de Lyon, 59, boulevard Pinel, 69677 Bron cedex, France.
| |
Collapse
|
38
|
Florentin A, Acouetey DS, Remen T, Penven E, Thaon I, Zmirou-Navier D, Paris C. Exhaled nitric oxide and screening for occupational asthma in two at-risk sectors: bakery and hairdressing. Int J Tuberc Lung Dis 2015; 18:744-50. [PMID: 24903948 DOI: 10.5588/ijtld.13.0641] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Fractional exhaled nitric oxide (FENO) levels are increasingly being used in the diagnosis and management of asthma. However, this indicator has rarely been used to detect occupational asthma. OBJECTIVE To examine non-invasive methods to estimate airway inflammation. METHODS A nested case-control study was conducted among a retrospective cohort of young workers in the bakery, pastry-making and hairdressing industries. Subjects underwent a clinical examination during a medical visit. Blood samples were collected and FENO levels measured. Cases were subjects diagnosed as suffering from 'confirmed' or 'probable' occupational asthma. RESULTS Of the 178 workers included in the study, 19 were cases. In univariate analysis, FENO was associated with case/control status, and height and smoking status. In a multiple linear regression model, case/control status (P < 0.001), height (P = 0.006) and smoking status (P < 0.001) remained independent risk factors for variations in FENO levels. Good or fair sensitivity of respectively around 80% and 70% can be achieved using low FENO thresholds (8.5 and 10.5 ppb, respectively). FENO >8.5 ppb and a positive clinical examination increases specificity without loss of sensitivity (to 80.5% and 79.0%, respectively). CONCLUSION This study suggests that FENO measurements alone cannot be considered a useful screening test for occupational asthma. Further investigations are needed to investigate the use of combined FENO and questionnaire or repeated measures.
Collapse
Affiliation(s)
- A Florentin
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| | - D-S Acouetey
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| | - T Remen
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| | - E Penven
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| | - I Thaon
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| | - D Zmirou-Navier
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| | - C Paris
- Lorraine University, INteractions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), EA 7298, Vandœuvre-les-Nancy, France
| |
Collapse
|
39
|
Penven E, Poussel M, Thaon I, Paris C. Occupational asthma to dried tobacco leaves: a very delayed diagnosis. J Investig Allergol Clin Immunol 2015; 25:144-5. [PMID: 25997313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023] Open
|
40
|
Bensefa-Colas L, Telle-Lamberton M, Paris C, Faye S, Stocks S, Luc A, Bourrain JL, Crépy MN, Dupas D, Frimat P, Garnier R, Lehucher-Michel MP, Pairon JC, Soulat JM, Lasfargues G, Choudat D, Momas I. Occupational allergic contact dermatitis and major allergens in France: temporal trends for the period 2001-2010. Br J Dermatol 2014; 171:1375-85. [DOI: 10.1111/bjd.13133] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/15/2014] [Indexed: 01/17/2023]
Affiliation(s)
- L. Bensefa-Colas
- Occupational Diseases Department; University Hospital of Centre of Paris COCHIN; AP-HP; 27 rue du faubourg Saint Jacques 75014 Paris France
- Laboratoire Santé Publique et Environnement; Paris Descartes University; Sorbonne Paris Cité EA 4064 Paris France
| | | | - C. Paris
- EA-7298 INGRES; Lorraine University; Vandoeuvre Les Nancy France
- Occupational Diseases Department; University Hospital; Nancy France
| | - S. Faye
- Agence Nationale de Sécurité Sanitaire (ANSES); Maisons-Alfort France
| | - S.J. Stocks
- Centre for Occupational and Environmental Health; Centre for Epidemiology; Institute of Population Health; University of Manchester; Oxford Road Manchester M13 9PT U.K
| | - A. Luc
- EA-7298 INGRES; Lorraine University; Vandoeuvre Les Nancy France
| | - J.-L. Bourrain
- Occupational Diseases Department; CHU de Grenoble; 38043 Grenoble Cedex 9 France
| | - M.-N. Crépy
- Occupational Diseases Department; University Hospital of Centre of Paris COCHIN; AP-HP; 27 rue du faubourg Saint Jacques 75014 Paris France
| | - D. Dupas
- Occupational Diseases Department; University Hospital; Nantes France
| | - P. Frimat
- Occupational Diseases Department; University Hospital; Lille France
| | - R. Garnier
- Occupational Diseases Department; APHP; Denis Diderot University; Paris France
| | - M.-P. Lehucher-Michel
- Occupational Diseases Department; Aix-Marseille University; EA 3279 Marseille France
| | - J.-C. Pairon
- Inserm U 955; Occupational Diseases Department; Centre Hospitalier Intercommunal de Créteil; Créteil France
| | - J.-M. Soulat
- Occupational Diseases Department; University Hospital; Toulouse France
| | - G. Lasfargues
- Agence Nationale de Sécurité Sanitaire (ANSES); Maisons-Alfort France
| | - D. Choudat
- Occupational Diseases Department; University Hospital of Centre of Paris COCHIN; AP-HP; 27 rue du faubourg Saint Jacques 75014 Paris France
| | - I. Momas
- Laboratoire Santé Publique et Environnement; Paris Descartes University; Sorbonne Paris Cité EA 4064 Paris France
| | | |
Collapse
|
41
|
Alisi A, Bedogni G, Baviera G, Giorgio V, Porro E, Paris C, Giammaria P, Reali L, Anania F, Nobili V. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2014; 39:1276-85. [PMID: 24738701 PMCID: PMC4046270 DOI: 10.1111/apt.12758] [Citation(s) in RCA: 292] [Impact Index Per Article: 29.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2014] [Revised: 02/11/2014] [Accepted: 03/27/2014] [Indexed: 02/06/2023]
Abstract
BACKGROUND Gut microbiota modifiers may have beneficial effects of non-alcoholic fatty liver disease (NAFLD) but randomised controlled trials (RCT) are lacking in children. AIM To perform a double-blind RCT of VSL#3 vs. placebo in obese children with biopsy-proven NAFLD. METHODS Of 48 randomised children, 44 (22 VSL#3 and 22 placebo) completed the study. The main outcome was the change in fatty liver severity at 4 months as detected by ultrasonography. Secondary outcomes were the changes in triglycerides, insulin resistance as detected by the homoeostasis model assessment (HOMA), alanine transaminase (ALT), body mass index (BMI), glucagon-like peptide 1 (GLP-1) and activated GLP-1 (aGLP-1). Ordinal and linear models with cluster confidence intervals were used to evaluate the efficacy of VSL#3 vs. placebo at 4 months. RESULTS At baseline, moderate and severe NAFLD were present in 64% and 36% of PLA children and in 55% and 45% of VSL#3 children. The probability that children supplemented with VSL#3 had none, light, moderate or severe FL at the end of the study was 21%, 70%, 9% and 0% respectively with corresponding values of 0%, 7%, 76% and 17% for the placebo group (P < 0.001). No between-group differences were detected in triglycerides, HOMA and ALT while BMI decreased and GLP-1 and aGLP1 increased in the VSL#3 group (P < 0.001 for all comparisons). CONCLUSIONS A 4-month supplement of VSL#3 significantly improves NAFLD in children. The VSL#3-dependent GLP-1 increase could be responsible for these beneficial effects. Trial identifier: NCT01650025 (www.clinicaltrial.gov).
Collapse
Affiliation(s)
- A. Alisi
- Hepato-Metabolic Disease Unit and Liver Research Unit, “Bambino Gesù” Children’s Hospital, IRCCS, Rome, Italy
| | - G. Bedogni
- Clinical Epidemiology Unit, Liver Research Center, Basovizza, Trieste, Italy
| | | | - V. Giorgio
- Hepato-Metabolic Disease Unit and Liver Research Unit, “Bambino Gesù” Children’s Hospital, IRCCS, Rome, Italy
| | - E. Porro
- Family paediatrician, Rome, Italy
| | - C. Paris
- Family paediatrician, Rome, Italy
| | | | - L. Reali
- Family paediatrician, Rome, Italy
| | - F. Anania
- Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia
| | - V. Nobili
- Hepato-Metabolic Disease Unit and Liver Research Unit, “Bambino Gesù” Children’s Hospital, IRCCS, Rome, Italy
| |
Collapse
|
42
|
Chaouat A, Sitbon O, Mercy M, Poncot-Mongars R, Provencher S, Guillaumot A, Gomez E, Selton-Suty C, Malvestio P, Regent D, Paris C, Herve P, Chabot F. Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension. Eur Respir J 2014; 44:704-13. [DOI: 10.1183/09031936.00153613] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
43
|
Rémen T, Acouetey DS, Paris C, Hannhart B, Poussel M, Chenuel B, Barbaud A, Zmirou-Navier D. Early incidence of occupational asthma is not accelerated by atopy in the bakery/pastry and hairdressing sectors. Int J Tuberc Lung Dis 2014; 17:973-81. [PMID: 23743318 DOI: 10.5588/ijtld.12.0864] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
SETTING Occupational asthma (OA) is most likely to develop in the very early years of exposure. OBJECTIVE To describe the early incidence of OA among bakers/pastry-makers (BP) and hairdressers and to explore the role of atopy. DESIGN Following a retrospective follow-up design, subjects were invited to undergo telephone interviews. Those who declared work-related respiratory or rhinitis symptoms and a sample group of others were offered a medical visit for OA investigations. Data from interviews and from medical visits were used to estimate the incidence of OA according to increasing durations of exposure. RESULTS A total of 866 subjects were interviewed (mean age 25.3 years, 43.8% females), of whom 282 underwent a medical visit. Total estimated incidence rates of 'confirmed or probable' OA during the first 12 years of exposure were high in BP (2.63 per 100 person-years [py]) and in hairdressers (0.58/100 py), particularly in the first 4 years. Atopy is a strong risk factor for incidence among BP but, irrespective of the occupational sector, it does not influence the timing of OA symptoms. CONCLUSION OA symptoms occur soon after the start of exposure. Our results suggest that atopy does not precipitate the occurrence of symptoms in two different allergen exposure settings.
Collapse
Affiliation(s)
- T Rémen
- Institut National de la Santé et de la Recherche Médicale U954, School of Medicine, Vandœuvre-lès-Nancy, France.
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Poreaux C, Waton J, François F, Paris C, Barbaud A. Caractéristiques des dermatites de contact aux protéines d’origine professionnelle. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
45
|
Mével H, Penven E, Wild P, Demange V, Paris C. Allergies respiratoires professionnelles et interactions gènes-environnement (ARPEIGE) – Sévérité et contrôle des asthmes en relation avec le travail. ARCH MAL PROF ENVIRO 2013. [DOI: 10.1016/j.admp.2013.09.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
46
|
Chanson C, Leonard M, Thaon I, Penven E, Speyer E, Paris C. Reconnaissance des psychopathologies par les comités régionaux de reconnaissance des maladies professionnelles de Lorraine entre 2005 et 2011. ARCH MAL PROF ENVIRO 2013. [DOI: 10.1016/j.admp.2012.11.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Gislard A, Schorle E, Letourneux M, Ameille J, Brochard P, Clin B, Conso F, Laurent F, Luc A, Paris C, Pairon JC. Déclaration et reconnaissance en maladie professionnelle après dépistage tomodensitométrique de maladies pleuropulmonaires bénignes dans le programme multirégional de surveillance postprofessionnelle de personnes exposées à l’amiante. Rev Epidemiol Sante Publique 2013; 61:11-20. [DOI: 10.1016/j.respe.2012.06.402] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2011] [Revised: 05/23/2012] [Accepted: 06/07/2012] [Indexed: 10/27/2022] Open
|
48
|
Chauvet C, Ménard C, Paris C, Tordjman I, Verger P, Fontaine M, Maladry P, Ruetsch M. État des lieux des sources d’information sur la prévention primaire des cancers d’origine professionnelle pour les médecins du travail : besoins et perspectives. ARCH MAL PROF ENVIRO 2012. [DOI: 10.1016/j.admp.2012.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
49
|
Afzal MI, Boulahya KA, Paris C, Delaunay S, Cailliez-Grimal C. Effect of oxygen on the biosynthesis of flavor compound 3-methylbutanal from leucine catabolism during batch culture in Carnobacterium maltaromaticum LMA 28. J Dairy Sci 2012. [PMID: 23182362 DOI: 10.3168/jds.2012-6088] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
In this study, we demonstrated the effect of different dissolved oxygen concentrations (DOC) on cell growth and intracellular biosynthesis of 3-methylbutanal from leucine catabolism in Carnobacterium maltaromaticum LMA 28 during batch culture. The maximum specific growth rate was obtained in culture when DOC was controlled at 50% of air saturation. The specific consumption rates of glucose and specific production rates of lactate were higher at a DOC at 50 or 90% of air saturation. Carnobacterium maltaromaticum LMA 28 produced high quantities of 3-methylbutanal and 3-methylbutanol during culture with DOC maintained at 90%, suggesting that oxygen had a significant effect of the formation of these flavor compounds. This high formation of flavor compounds in an oxygen-rich environment was attributed to the simultaneous activation and stimulation of both α-ketoacid decarboxylase (KADC) and α-ketoacid dehydrogenase (KADH) pathways. Thus, intracellular biosynthesis of 3-methylbutanal can be controlled by modifying the DOC of the culture or food product during fermentation.
Collapse
Affiliation(s)
- M I Afzal
- Laboratoire d'ingénierie des biomolécules, Université de Lorraine, 2 avenue de la Forêt de Haye B.P. 172, Vandoeuvre-lès-Nancy F-54505, France
| | | | | | | | | |
Collapse
|
50
|
Bourgkard E, Gonzalez M, Bannay A, Bonnet N, Rollin G, Feicht G, Févotte J, Wild P, Paris C. Estimation rétrospective des expositions professionnelles dans une étude cas–témoin sur le cancer bronchique. Évaluation d’un questionnaire « tâches ». ARCH MAL PROF ENVIRO 2012. [DOI: 10.1016/j.admp.2012.09.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|